Skirting the pitfalls: A clear-cut nomenclature for H3K4 methyltransferases

Clinical Genetics

Volumn 83, Issue 3, 2013, Pages 212-214

  Bogershausen N ^a   Bruford, E ^b   Wollnik, B ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

Author keywords

Chromatin modifying enzymes; Kabuki syndrome; KMT2; KMT2B; KMT2D; MLL; MLL2; MLL4; Nomenclature

Indexed keywords

METHYLTRANSFERASE;

GENE IDENTIFICATION; GENE MUTATION; HIGH THROUGHPUT SEQUENCING; HUMAN; MULTIGENE FAMILY; NOMENCLATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW;

ABNORMALITIES, MULTIPLE; ANIMALS; DNA-BINDING PROTEINS; FACE; HEMATOLOGIC DISEASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; MUTATION; NEOPLASM PROTEINS; SYNDROME; TERMINOLOGY AS TOPIC; VESTIBULAR DISEASES;

EID: 84874018873     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12050     Document Type: Review

References (13)

1. Ng SB, Bigham AW, Buckingham KJ et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010: 42: 790-793.
2. FitzGerald KT, Diaz MO. MLL2: a new mammalian member of the trx/MLL family of genes. Genomics 1999: 59: 187-192.
3. Cho YW, Hong T, Hong S et al. PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem 2007: 282: 20395-20406.
4. Glaser S, Lubitz S, Loveland KL et al. The histone 3 lysine 4 methyltransferase, Mll2, is only required briefly in development and spermatogenesis. Epigenetics Chromatin 2009: 2: 5.
5. Natarajan TG, Kallakury BV, Sheehan CE et al. Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon. Cancer Cell Int 2010: 10: 13.
6. Issaeva I, Zonis Y, Rozovskaia T et al. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol Cell Biol 2007: 27: 1889-1903.
7. Lee S, Roeder RG, Lee JW. Roles of histone H3-lysine 4 methyltransferase complexes in NR-mediated gene transcription. Prog Mol Biol Transl Sci 2009: 87: 343-382.
8. Jones WD, Dafou D, McEntagart M et al. De novo Mutations in MLL Cause Wiedemann-Steiner syndrome. Am J Hum Genet 2012: 91 (2): 358-364.
9. Kleefstra T, Kramer JM, Neveling K et al. Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. Am J Hum Genet 2012: 91 (1): 73-82.
10. Allis CD, Berger SL, Cote J et al. New nomenclature for chromatin-modifying enzymes. Cell 2007: 131: 633-636.
11. Sebastian S, Sreenivas P, Sambasivan R et al. MLL5, a trithorax homolog, indirectly regulates H3K4 methylation, represses cyclin A2 expression, and promotes myogenic differentiation. Proc Natl Acad Sci USA 2009: 24: 4719-4724.
12. Lederer D, Grisart B, Digilio MC et al. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet 2012: 90 (1): 119-124.
13. Smith E, Lin C, Shilatifard A. The super elongation complex (SEC) and MLL in development and disease. Genes Dev 2011: 25: 661-672.